Pornography Abstinence and Nocturnal Erections in Adult Men
A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men
The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.
Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.
During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.
Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.
Study Design
Study Type: Observational
Study Design: Single-arm, within-participant comparison
Time Perspective: Prospective
Masking: None (Open Label)
Primary Purpose: Health outcomes assessment / signal detection
Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Matthew Amsden
- Numéro de téléphone: (646) 679-2479
- E-mail: help@efforia.com
Lieux d'étude
-
-
New York
-
New York, New York, États-Unis, 10003
- Recrutement
- Efforia
-
Contact:
- Matthew Amsden
- Numéro de téléphone: (646) 679-2479
- E-mail: help@efforia.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Adult males of legal age of consent
- Willingness to attempt pornography abstinence
- Ability to use a wearable device during sleep
- Ability to complete electronic surveys
- Willingness to purchase the study device
Exclusion Criteria:
- Have a history of significant sexual dysfunction requiring active medical treatment
- Have current or uncontrolled mental health disorders
- Have a history of addictive behaviors that may be exacerbated by abstinence
- Are undergoing hormonal therapy or treatment affecting sexual function
- Are experiencing unstable interpersonal or relationship stressors
- Have significant concerns about privacy related to sexual health data
- Have cultural or religious considerations that could cause distress
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Single Arm longitudinal where participants act as their own control
|
Participants will attempt to abstain from all pornography use for 30 consecutive days.
Any deviations from abstinence are self-reported and logged for contextual analysis.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Nocturnal Penile Tumescence
Délai: Baseline Day to Day 38
|
Measure: Adam Sensor - Nocturnal Erection Tracking Description: Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night |
Baseline Day to Day 38
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Erectile Function
Délai: Baseline to Day 38 after intervention
|
Measure: International Index of Erectile Function (IIEF-15) Scale Range: 5-75 (higher scores indicate better erectile and sexual function) Description: Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. |
Baseline to Day 38 after intervention
|
|
Change in Sexual Desire
Délai: Baseline to Day 38 after intervention
|
Measure: Sexual Desire Inventory-2 (SDI-2) Scale Range: 0-112 (higher scores indicate greater sexual desire) Description: Measures both dyadic and solitary sexual desire. |
Baseline to Day 38 after intervention
|
|
Change in Pornography Consumption Patterns
Délai: Baseline to Day 38 after intervention
|
Measure: Weekly Pornography Consumption Survey (custom self-report) Scale: Frequency and duration categories (ordinal) Description: Tracks self-reported pornography use and abstinence adherence. |
Baseline to Day 38 after intervention
|
|
Change in Mood, Energy, and Emotional Well-Being
Délai: Baseline to Day 38 after intervention
|
Measure: Weekly Self-Assessment Check-In (custom) Scale: 1-10 Likert-type scales (higher scores indicate more favorable states) Description: Assesses perceived mood, mental clarity, energy level, and emotional resilience. |
Baseline to Day 38 after intervention
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 38321
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .